Showing results (811-820 of 3,617) with videos related to

Sort By:
Pageof 362
Current Opinion in Rheumatology|March 26, 2009
The BeSt story: on strategy trials in rheumatoid arthritisNaomi B Klarenbeek, Cornelia F Allaart, Pit J S M Kerstens, et al.
Pharmacogenomics|June 23, 2017
Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritisFrank Eektimmerman, Jesse J Swen, Stefan Böhringer, et al.
Pharmacogenomics|February 9, 2010
Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritisWouter M Kooloos, Judith Am Wessels, Tahar van der Straaten, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2023
Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancerC Dickhoff, S Unal, D J Heineman, et al.
The Annals of Thoracic Surgery|January 29, 2019
In-Hospital Mobilization, Physical Fitness, and Physical Functioning After Lung Cancer SurgeryMarike van der Leeden, Chloé Balland, Edwin Geleijn, et al.
Investigative Ophthalmology & Visual Science|May 4, 2010
Conditions of retinal glial and inflammatory cell activation after irradiation in a GFP-chimeric mouse modelPhilipp S Müther, Irina Semkova, Kristina Schmidt, et al.
Respiratory Medicine Case Reports|June 2, 2015
Pneumomediastinum and (bilateral) pneumothorax after high energy trauma: Indications for emergency bronchoscopyMartijn R Groenendijk, Koen J Hartemink, Chris Dickhoff, et al.
International Journal of Pharmaceutics: X|January 18, 2024
Batch vs. continuous direct compression - a comparison of material processability and final tablet qualityB Bekaert, P H M Janssen, S Fathollahi, et al.
Journal of Lipid Research|November 5, 1997
A novel apolipoprotein C-III variant, apoC-III(Gln38-->Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican originC R Pullinger, M J Malloy, A K Shahidi, et al.
Anaesthesia|April 18, 2014
Cardiovascular autonomic function testing under non-standardised and standardised conditions in cardiovascular patients with type-2 diabetes mellitusS W M Keet, C S E Bulte, A Sivanathan, et al.
Pageof 362